SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
227 hedge funds and large institutions have $308M invested in Sorrento Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% less funds holding
Funds holding: 233 → 227 (-6)
Holders
227
Holding in Top 10
–
Calls
$11.4M
Puts
$3.47M
Top Buyers
| 1 | +$24M | |
| 2 | +$11.5M | |
| 3 | +$10M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.83M |
| 5 |
Citigroup
New York
|
+$2.7M |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$2.73M | |
| 3 | -$2.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.07M |
| 5 |
Two Sigma Investments
New York
|
-$1.58M |